article thumbnail

NMC Guidelines Is It Branded Vs. Generic Medicines or Branded & Generic Medicines?

PharmaState Academy

The conversation led by Gauri Chaudhari ended with Gauri Chaudhari saying it should be ‘BRANDED & GENERIC MEDICINES’. The major issues involved in the NMC decision is the price of branded medicines. In the first place are our branded generic medicines really expensive? I fully agree with her.

article thumbnail

Opinion: I went on a mind-boggling journey to get my son’s ADHD medication covered by insurance — twice

STAT

As a former editor for diabetes publications, I knew that insurance companies regularly switched people from one brand of insulin to another, or from a name brand of insulin to a generic. However, I had used generic medicine for my blood pressure without a problem, so I hoped for the best with this switch.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies

STAT

A growing number of alternative pharmacies — such as those run by Costco, Amazon, and Mark Cuban Cost Plus Drugs — may be increasingly popular with American consumers, but a new analysis finds many of the most expensive generic medicines are unavailable, prices vary widely, and savings can be modest.

article thumbnail

Zeno Health secures $25 million in Series C funding

Express Pharma

Zeno Health, an omnichannel platform for generic medicines, announced the successful closure of its Series C funding round, securing a total of $5 million. In the five years since we invested in Zeno, the company has created the country’s largest omnichannel pharmacy platform for quality and affordable generic medicines.

article thumbnail

STAT+: Generic makers fall short when providing access to low- and middle-income countries, analysis finds

STAT

A handful of the largest purveyors of generic medicines have made only halting progress to ensure their drugs are accessible for patients in low- and middle-income countries, a new analysis found.

article thumbnail

FTC targets middlemen in generic drug shortages probe

pharmaphorum

The FTC is investigating wholesalers and other middlemen in the pharma supply chain to assess their possible role in worsening shortages of generic medicines

article thumbnail

STAT+: FTC challenges several big drugmakers over inaccurate or improper patent listings

STAT

The move comes two months after the FTC issued a policy statement noting some drug companies have failed to follow requirements for listing patents in the Food and Drug Administration’s Orange Book in hopes of thwarting competition from lower-cost generic medicines. Continue to STAT+ to read the full story…